CUV 0.64% $13.87 clinuvel pharmaceuticals limited

shareholder corporate action, page-24

  1. 8,309 Posts.
    lightbulb Created with Sketch. 164
    I think AVX had some catching up to do compared to CUV over the last 12 months.

    Look, the one thing that really went our way was CUV raising enough money before the GFC and not having to tap the market for more money and diluting our holdings....like so many other companies.

    If the Phse 2 and 3 trilas come off, along with marketung in EU....CUV is a sleeping giant imo.

 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.